Search - Prime Therapeutics
Navigate to
-
U.S. News & World Report
PA Sub-Categories: GLP-1 Prime Article: In the News -
Specialty Pharmacy Continuum
PA Sub-Categories: GLP-1 Prime Article: In the News -
Forbes
PA Sub-Categories: GLP-1 Prime Article: In the News -
Publications Clinical Highlights: November 2024 Your monthly source for drug information highlights. November 27, 2024 Weight Management Corner: catch up on recent publications and study findings...
-
Gene therapy harnesses the body’s capacity to heal itself
Prime Article: Perspectives -
Managed Healthcare Executive: Prior authorization using integrated medical claims data helps diabetes patients get medications faster, with two-thirds processed automatically by July 2025 in this...
PA Sub-Categories: Specialty drugs Prime Article: In the News -
Prime Therapeutics Report shares more about single-treatment gene therapies and proper management
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Cover image for The evolution of GLP-1s Developing a holistic, individualized strategy to capitalize on opportunities and outcomes Prime Therapeutics /the-evolution-of-glp-1s About Prime...
Prime Article: Research & Publications PA Research & Publications: White Papers -
New report explores traditional, specialty therapy trend impact to employers
PA Sub-Categories: Specialty drugs Prime Article: Stories -
publications Metabolic dysfunction–associated steatohepatitis (MASH) A new era in liver health: Treatment innovation, payer strategy, and pipeline momentum August 15, 2025 Prime Therapeutics’...
-
From next-gen CFTR modulators to gene therapy and real-world drug impact, cystic fibrosis care is constantly evolving. Maryam Tabatabai, PharmD, of Prime Therapeutics, explains how innovative...
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Publications Clinical Highlights: February 2025 Your monthly source for drug information highlights. February 28, 2025 Trending topics The annual report Cancer statistics, 2025 from the American...
-
PUBLICATIONS FDA Decisions Expected: October 2025 Your monthly synopsis of new drugs expected to hit the market September 17, 2025 Drug pipeline for October 2025 At Prime Therapeutics (Prime), we...
-
cover image for Summer 2025 Issue: Clinical Insights – MASH A new era in liver health: Treatment innovation, payer strategy, and pipeline momentum Prime Therapeutics...
Prime Article: Research & Publications PA Research & Publications: Clinical Insights White Papers -
Learn with Biosimilar Basics. Part 2 covers biosimilar naming conventions and other nomenclature including common drug pipeline content acronyms.
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
publications High-Cost Therapy Profile: September 2025 Clemidsogene Ianparvovec Intracisternal | Regenxbio / Nippon Shinyaku Metabolic-gene therapy September 22, 2025 Proposed indications ...
-
Breadcrumb Home Newsroom Custom Content Publications Clinical Highlights: September 2024 PUBLICATIONS Clinical Highlights: September 2024 Your monthly source for drug information highlights....
-
Prime Therapeutics clinical experts shared insights on the specialty drug pipeline at recent industry event
PA Sub-Categories: Specialty drugs Prime Article: Stories -
A roundup of Prime's award-winning presentations and insights at AMCP Annual Meeting in Houston
PA Sub-Categories: GLP-1 Technology Awards Prime Article: Stories -
Critical updates in an ever-changing environment
Prime Article: Research & Publications PA Research & Publications: Drug Approvals